Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exploding the albumin myth.

M M Tjoeng1, A K Bartelink, L G Thijs

  • 1Dept Clinical Pharmacology, Eemland Hospital, Amersfoort, The Netherlands.

Pharmacy World & Science : PWS
|April 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discontinuation of anticoagulant care during admission to a psychiatric hospital.

European journal of clinical pharmacology·2012
Same author

Acute adrenal insufficiency due to bilateral adrenal hemorrhage.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)·2011
Same author

Adrenal dysfunction in critical illness: a clinical entity that requires treatment?

Current opinion in anaesthesiology·2006
Same author

Association of furunculosis and familial deficiency of mannose-binding lectin.

European journal of clinical investigation·2005
Same author

Optimisation of the antibiotic guidelines in The Netherlands. VII. SWAB guidelines for antimicrobial therapy in adult patients with infectious endocarditis.

The Netherlands journal of medicine·2004
Same author

[Optimalization of antibiotic policy in the Netherlands. VII. SWAB-guidelines for antimicrobial therapy in adults patients with infectious endocarditis].

Nederlands tijdschrift voor geneeskunde·2003
Same journal

In Memoriam.

Pharmacy world & science : PWS·2018
Same journal

UKCPA News.

Pharmacy world & science : PWS·2018
Same journal

Severe akathisia as a side effect of metoclopramide.

Pharmacy world & science : PWS·2010
Same journal

Introduction of pharmaceutical expertise in a palliative care team in Sweden.

Pharmacy world & science : PWS·2010
Same journal

Cost reduction associated with restriction policy on dispensing intravenous esomeprazole in Lebanon.

Pharmacy world & science : PWS·2010
Same journal

Azathioprine-induced severe cholestatic hepatitis in patient carrying TPMT*3C polymorphism.

Pharmacy world & science : PWS·2010
See all related articles

Current albumin infusion practices for patients in shock are questioned. Albumin levels do not impact survival or morbidity, suggesting alternative fluid therapies are preferable for septic shock management.

Area of Science:

  • Critical Care Medicine
  • Biochemistry
  • Pharmacology

Background:

  • Serum albumin is a key protein in plasma, influencing oncotic pressure and transport.
  • Patients in shock, particularly septic shock, often exhibit low serum albumin levels.
  • Albumin infusion is a common therapeutic intervention in these critical care settings.

Purpose of the Study:

  • To evaluate the efficacy of albumin infusion in patients with shock and hypoalbuminemia.
  • To determine if correcting serum albumin levels improves patient survival and reduces morbidity.
  • To assess the role of fluid therapy and synthetic plasma expanders as alternatives.

Main Methods:

  • Review of existing clinical data and studies on albumin infusion in shock.
  • Analysis of correlation between albumin levels, infusion, and patient outcomes (survival, morbidity).

Related Experiment Videos

  • Comparison of albumin therapy with standard fluid resuscitation protocols.

    • Main Results:

    • No significant correlation found between corrected albumin levels and improved survival rates.
    • Albumin infusion did not demonstrate a reduction in morbidity in the studied patient population.
    • Fluid therapy, including synthetic plasma expanders, remains the standard of care.

    Conclusions:

    • The current practice of infusing albumin in shock patients should be reconsidered.
    • Albumin administration does not appear to be linked to better patient outcomes.
    • Alternative fluid management strategies are recommended for septic shock treatment.